"Performance" SINOMAB BIO-B's mid-term loss narrows to 49.82 million RMB

AASTOCKS
2025.08.31 14:04

SINOMAB BIO-B (03681.HK) announced its interim results for the six months ending in June, recording total other income and gains of RMB 9.8 million (same below). Losses narrowed from RMB 90.62 million in the same period last year to RMB 49.82 million, with a loss per share of 5 cents. No dividend is declared

Source: AASTOCKS The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.